China News Service, April 13th. According to U.S. media reports, the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) issued a statement on the 13th that it is recommended to suspend the use of Johnson & Johnson’s new crown vaccine. Report 6 cases of "rare and severe" thrombosis after vaccination with Johnson & Johnson.

  The CDC's Immunization Practice Advisory Committee will meet on the 14th to discuss these cases, and the FDA has also begun investigating these cases.